US regulator rejects Novartis heart failure drug Reuters About five million people in the United States are living with chronic heart failure, a progressive weakening of the heart, according to Novartis. About one million are hospitalized with episodes of acute heart failure, and about 22 percent of patients ... FDA Rejects Novel Novartis Drug For Acute Heart Failure FDA Says No to Serelaxin for Heart Failure |
